Novel Antibody Under Development for Type 1 Diabetes

Share this content:

A new product known as BL-9020 is being developed by Israeli researchers to help protect pancreatic beta cells in the early stages of diabetes diagnosis.

John Schieszer has the latest in today's Medical Minute.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters